Silverarc Capital Management, LLC Vaxart, Inc. Transaction History

Silverarc Capital Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$0.41 - $0.94 $161,522 - $370,319	-393,957 Reduced 36.55%	683,825 $280,000
Q4 2024 Feb 14, 2025	BUY	$0.54 - $0.86 $42,002 - $66,892	77,782 Added 7.78%	1,077,782 $711,000
Q3 2024 Nov 14, 2024	BUY	$0.58 - $0.99 $580,000 - $990,000	1,000,000 New	1,000,000 $850,000

105

23.1M

50.3K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $48.1M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Silverarc Capital Management, LLC with notifications on news.